AZN vs KMTS · P/E 28, $288.38B cap vs rev $95.1M
AstraZeneca PLC (AZN) versus Kestra Medical Technologies, Ltd. Common Stock (KMTS) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Kestra Medical Technologies, Ltd. Common Stock (KMTS) is a medical instruments & supplies company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported KMTS revenue for 2026-04-30 was $95.1M. Net income was -$131.6M. Revenue was up 59.0% from 2025-04-30 to 2026-04-30. KMTS currently screens at market cap $1.24B.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. KMTS currently screens at market cap $1.24B.
Not investment advice. Open the AZN and KMTS stock pages for the full models.
Not investment advice.